UPDATE: JPMorgan Downgrades Clovis Oncology (CLVS) to Underweight, 'Going-Concern Risk with Runway Ending in January'
Tweet Send to a Friend
(Updated - November 9, 2022 4:03 PM EST)
JPMorgan analyst Brian Cheng downgraded Clovis Oncology (NASDAQ: CLVS) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Brian Cheng downgraded Clovis Oncology (NASDAQ: CLVS) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
